先天性大疱性表皮松解症诊断及治疗进展

中华皮肤科杂志 ›› 2016, Vol. 49 ›› Issue (7): 516-519.

先天性大疱性表皮松解症诊断及治疗进展

于灵,冯素英

中国医学科学院皮肤病研究所皮肤病医院

收稿日期:2015-07-29 修回日期:2016-02-18 发布日期:2016-06-30
通讯作者: 冯素英 E-mail:fengsuying2010@aliyun.com

Update on the diagnosis and treatment of inherited epidermolysis bullosa

Received:2015-07-29 Revised:2016-02-18 Published:2016-06-30

摘要/Abstract

摘要：

先天性大疱性表皮松解症是一组以皮肤脆性增加、轻微摩擦或外伤即可导致皮肤或黏膜水疱、糜烂为共同特点的遗传性皮肤病。目前该病可分为4型，即单纯型、交界型、营养不良型和Kindler综合征型。诊断方面，提倡“洋葱皮诊断方法”，即先进行免疫荧光定位，而后针对性进行基因检测明确致病基因位点。治疗上要加强护理，药物、手术对症治疗可缓解不适症状。细胞、蛋白、基因治疗等方面研究不断深入有望为患者带来希望，及时进行产前诊断，避免不良后果的发生。

Abstract:

Yu Ling, Feng Suying Department of Dermatology, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China Corresponding author: Feng Suying, Email: suying_f@yahoo.com 【Abstract】 Inherited epidermolysis bullosa （EB） is a group of hereditary skin diseases characterized by increases in skin brittleness and being prone to skin blisters or erosions when the skin is exposed to slight friction or injury. At present, it is classified into four types, namely EB simplex, junctional EB, dystrophic EB and Kindler syndrome. An "onion skinning" approach is recommended for the diagnosis of inherited epedermolysis bullosa, in which, immunofluorescence mapping is performed firstly, and causative genetic loci are then determined through detection of relevant genes. In its treatment, skin care should be intensified, and medical or surgical treatment may be used to alleviate symptoms. Further development of cell?, protein? and gene?based therapies is expected to bring hope to patients via realization of timely prenatal diagnosis and avoidance of adverse consequences.

于灵冯素英. 先天性大疱性表皮松解症诊断及治疗进展[J]. 中华皮肤科杂志, 2016,49(7):516-519. doi:

参考文献 27

［1］	Fine JD, Eady RA, Bauer EA, et al. The classification of inherited epidermolysis bullosa （EB）: report of the Third International Consensus Meeting on Diagnosis and Classification of EB［J］. J Am Acad Dermatol, 2008, 58（6）: 931⁃950. DOI: 10.1016/j.jaad.2008.02.004.
［2］	Fine JD, Bruckner⁃Tuderman L, Eady RA, et al. Inherited epider⁃molysis bullosa: updated recommendations on diagnosis and classification［J］. J Am Acad Dermatol, 2014, 70（6）: 1103⁃1126. DOI: 10.1016/j.jaad.2014.01.903.
［3］	Intong LR, Murrell DF. Inherited epidermolysis bullosa: new diag⁃nostic criteria and classification［J］. Clin Dermatol, 2012, 30（1）:70⁃77. DOI: 10.1016/j.clindermatol.2011.03.012.
［4］	Cepeda⁃Valdés R, Pohla⁃Gubo G, Borbolla⁃Escoboza JR, et al.Immunofluorescence mapping for diagnosis of congenital epider⁃molysis bullosa［J］. Actas Dermosifiliogr, 2010, 101（8）: 673⁃682.
［5］	Berk DR, Jazayeri L, Marinkovich MP, et al. Diagnosing epider⁃molysis bullosa type and subtype in infancy using immuno⁃fluorescence microscopy: the Stanford experience［J］. Pediatr Dermatol, 2013, 30（2）: 226⁃233. DOI: 10.1111/j.1525⁃1470.2012.01880.x.
［6］	Yiasemides E, Walton J, Marr P, et al. A comparative study between transmission electron microscopy and immunofluorescence mapping in the diagnosis of epidermolysis bullosa［J］. Am J Dermatopathol, 2006, 28（5）: 387⁃394. DOI: 10.1097/01.dad.0000211510.44865.6d.
［7］	Petronius D, Bergman R, Ben IO, et al. A comparative study of immunohistochemistry and electron microscopy used in the diagnosis of epidermolysis bullosa［J］. Am J Dermatopathol, 2003,25（3）: 198⁃203.
［8］	El H M, Zambruno G, Bourdon⁃Lanoy E, et al. Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa［J］. Orphanet J Rare Dis, 2014, 9: 76. DOI: 10.1186/1750⁃1172⁃9⁃76.
［9］	Petersen BW, Arbuckle HA, Berman S. Effectiveness of saltwater baths in the treatment of epidermolysis bullosa［J］. Pediatr Dermatol, 2015, 32（1）: 60⁃63. DOI: 10.1111/pde.12409.
［10］	Fine JD, Manes B, Frangoul H. Systemic granulocyte colony⁃stimu⁃lating factor （G⁃CSF） enhances wound healing in dystrophic epidermolysis bullosa （DEB）: results of a pilot trial［J］. J Am Acad Dermatol, 2015, 73（1）: 56⁃61. DOI: 10.1016/j.jaad.2015. 04.015.
［11］	Lo V, Lara⁃Corrales I, Stuparich A, et al. Amniotic membrane grafting in patients with epidermolysis bullosa with chronic wounds［J］. J Am Acad Dermatol, 2010, 62（6）: 1038⁃1044. DOI: 10.1016/j.jaad.2009.02.048.
［12］	Tian F, Li B, Tian LJ. Treatment of severe hand deformities caused by epidermolysis bullosa［J］. Orthopedics, 2011, 34（11）:e780⁃783. DOI: 10.3928/01477447⁃20110922⁃37.
［13］	Diociaiuti A, Rotunno R, El Hachem M, et al. Electrochemotherapy, a potential new treatment for the management of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: report of three cases［J/OL］. J Eur Acad Dermatol Venereol, 2015. DOI: 10.1111/jdv.13116. http://onlinelibrary.wiley.com/enhanced/doi/10. 1111/jdv.13116.
［14］	Wong T, Gammon L, Liu L, et al. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa［J］. J Invest Dermatol, 2008, 128（9）: 2179⁃2189. DOI: 10.1038/jid.2008.78.
［15］	Woodley DT, Remington J, Huang Y, et al. Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing［J］. Mol Ther, 2007, 15（3）: 628⁃635. DOI: 10.1038/sj.mt.6300041.
［16］	Kim YS, Ahn Y, Kwon JS, et al. Priming of mesenchymal stem cells with oxytocin enhances the cardiac repair in ischemia/reperfusion injury［J］. Cells Tissues Organs, 2012, 195（5）: 428⁃442. DOI: 10.1159/000329234.
［17］	Tolar J, Wagner JE. A biologic Velcro patch［J］. N Engl J Med, 2015, 372（4）: 382⁃384. DOI: 10.1056/NEJMcibr1414709.
［18］	Tolar J, Wagner JE. Management of severe epidermolysis bullosa by haematopoietic transplant: principles, perspectives and pitfalls［J］. Exp Dermatol, 2012, 21（12）: 896⁃900. DOI: 10.1111/exd. 12014.
［19］	Nevala⁃Plagemann C, Lee C, Tolar J. Placenta⁃based therapies for the treatment of epidermolysis bullosa［J］. Cytotherapy, 2015, 17（6）: 786⁃795. DOI: 10.1016/j.jcyt.2015.03.006.
［20］	Bruckner⁃Tuderman L, McGrath JA, Robinson EC, et al. Progress in epidermolysis bullosa research: summary of DEBRA Inter⁃national Research Conference 2012［J］. J Invest Dermatol, 2013,133（9）: 2121⁃2126. DOI: 10.1038/jid.2013.127.
［21］	Cutlar L, Greiser U, Wang W. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa［J］. Exp Dermatol, 2014, 23（1）: 1⁃6. DOI: 10.1111/exd.12246.
［22］	Tolar J, Xia L, Lees CJ, et al. Keratinocytes from induced pluri⁃potent stem cells in junctional epidermolysis bullosa［J］. J Invest Dermatol, 2013, 133（2）: 562⁃565. DOI: 10.1038/jid.2012.278.
［23］	De Luca M, Pellegrini G, Mavilio F. Gene therapy of inherited skin adhesion disorders: a critical overview［J］. Br J Dermatol, 2009,161（1）: 19⁃24. DOI: 10.1111/j.1365⁃2133.2009.09243.x.
［24］	Krakowski AC, Ghasri P. Case report: rapidly healing epider⁃molysis bullosa wound after ablative fractional resurfacing［J/OL］. Pediatrics, 2015, 135（1）: e207⁃e210［2015⁃06⁃04］. DOI: 10.1542/ peds.2014⁃1779. http://pediatrics.aappublications.org/content/135/1/e207.long.
［25］	Swartling C, Karlqvist M, Hymnelius K, et al. Botulinum toxin in the treatment of sweat⁃worsened foot problems in patients with epidermolysis bullosa simplex and pachyonychia congenita［J］. Br J Dermatol, 2010, 163（5）: 1072⁃1076. DOI: 10.1111/j.1365⁃2133.2010.09927.x.
［26］	Tadini G, Pezzani L, Ghirardello S, et al. Cord blood platelet gel treatment of dystrophic recessive epidermolysis bullosa［J］. BMJ Case Rep, 2015, 2015. DOI: 10.1136/bcr⁃2014⁃207364.
［27］	姜薇, 孙莹, 赵俊郁, 等. Hallopeau⁃Siemens型营养不良型大疱性表皮松解症一例产前诊断［J］. 中华皮肤科杂志, 2006, 39（2）: 80⁃82. DOI: 10.3760/j.issn.0412⁃4030.2006.02.007.
	Jiang W, Sun Y, Zhao JY, et al, Prenatal diagnosis of Hallopeau⁃Siemens recessive dystrophic epidermolysis bullosa［J］. Chin J Dermatol, 2006, 39（2）: 80⁃82. DOI: 10.3760/j.issn.0412⁃4030. 2006.02.007.